About This LDL Cholesterol Calculator
This LDL Cholesterol Calculator is a clinical tool for healthcare professionals and patients to estimate LDL cholesterol levels using the Friedewald formula. By inputting standard lipid panel values—Total Cholesterol, HDL Cholesterol, and Triglycerides—this calculator provides an immediate estimation of LDL-C and Non-HDL-C. These values are essential for assessing cardiovascular risk and guiding lipid-lowering therapy according to established clinical guidelines.
The Formulas Explained
Friedewald Formula for LDL-C
This is the most widely used formula for estimating LDL-C. It assumes that VLDL-C (Very Low-Density Lipoprotein Cholesterol) can be estimated as one-fifth of the triglyceride concentration.
$$ \text{LDL-C} = [\text{Total Cholesterol}] – [\text{HDL-C}] – \frac{[\text{Triglycerides}]}{5} $$
Non-HDL-C Formula
Non-HDL cholesterol is a simple calculation that includes all cholesterol carried by atherogenic lipoproteins (LDL, VLDL, IDL). It is particularly useful when triglycerides are high.
$$ \text{Non-HDL-C} = [\text{Total Cholesterol}] – [\text{HDL-C}] $$
Clinical Interpretation & Limitations
The calculated LDL-C value helps classify cardiovascular risk based on NCEP ATP III guidelines.
- Optimal: < 100 mg/dL
- Near Optimal: 100-129 mg/dL
- Borderline High: 130-159 mg/dL
- High: 160-189 mg/dL
- Very High: ≥ 190 mg/dL
These NCEP ATP III bands are descriptive ranges, not treatment targets. Modern guidelines individualize LDL-C goals by cardiovascular risk: the 2019 ESC/EAS dyslipidaemia guideline recommends LDL-C <55 mg/dL and a ≥50% reduction from baseline for very-high-risk patients and <70 mg/dL for high-risk patients, while the 2018 ACC/AHA guideline uses risk-stratified thresholds (e.g., intensifying therapy when LDL-C remains ≥70 mg/dL in very-high-risk secondary prevention) rather than a single universal target.
Limitations
The accuracy of the Friedewald formula is dependent on the triglyceride level. The estimation of VLDL-C as TG/5 is not valid in the following situations:
- High Triglycerides: When TG levels are ≥ 400 mg/dL.
- Low LDL-C: Friedewald becomes less reliable (tends to underestimate) when LDL-C is < 70 mg/dL; a direct measurement or the Martin-Hopkins/Sampson-NIH equations are preferred in this range.
- Very Low Triglycerides: The formula may be less accurate when TG levels are very low (e.g., < 100 mg/dL).
- Genetic Conditions: In patients with familial dysbetalipoproteinemia (Type III hyperlipoproteinemia).
Frequently Asked Questions (FAQ)
1. Why is the Friedewald formula inaccurate when triglycerides are high?
The formula assumes a fixed ratio of triglycerides to VLDL cholesterol (5:1). In individuals with high triglycerides (hypertriglyceridemia), this ratio changes, and VLDL-C is no longer accurately reflected by TG/5. This leads to an underestimation of the calculated LDL-C value.
2. What is Non-HDL cholesterol and why is it important?
Non-HDL-C represents the cholesterol content of all lipoproteins considered to be atherogenic, including LDL, VLDL, and others. It is a robust marker of cardiovascular risk that is easy to calculate and is not affected by triglyceride levels, making it a valuable metric, especially when the Friedewald formula is unreliable.
3. What should I do if my triglycerides are over 400 mg/dL?
If your triglycerides are 400 mg/dL or higher, the calculated LDL-C is not reliable. Your healthcare provider will likely recommend a direct LDL-C measurement, which is a lab test that directly measures the amount of LDL cholesterol without relying on a calculation.
4. Does this calculator work for units other than mg/dL?
No. This calculator is specifically designed for lipid values reported in mg/dL. If your lab results are in mmol/L, they must be converted first.
5. Are there newer formulas to calculate LDL-C?
Yes. The Martin-Hopkins and Sampson-NIH equations provide more accurate LDL-C estimates, particularly at low LDL-C or with moderately high triglycerides. The 2018 ACC/AHA guideline supports (Class IIa) a direct measurement or a validated estimate such as Martin-Hopkins when calculated LDL-C is <70 mg/dL, and the Sampson-NIH equation remains valid at triglycerides up to 800 mg/dL. The Friedewald formula nonetheless remains the most widely used method for its simplicity, which is why this calculator uses it.
6. Do I need to fast before a lipid panel?
For routine screening, fasting is no longer required: both the 2018 ACC/AHA and the 2016 ESC/EAS consensus accept nonfasting lipid panels. Triglycerides (and therefore the Friedewald LDL-C estimate) run modestly higher after a meal, so when triglycerides are markedly elevated or are the main focus, a repeat fasting sample may be requested.
📖 Sources:
- Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 18(6), 499–502.
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2002). Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106(25), 3143–3421.
- Grundy, S. M., et al. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology, 73(24), e285-e350.
- Martin, S. S., et al. (2013). Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA, 310(19), 2061-2068. PMID: 24240933.
- Sampson, M., et al. (2020). A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA Cardiology, 5(5), 540-548. PMID: 32101259.
⚠️ Disclaimer:
This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.
